{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:16:13Z","timestamp":1766020573133,"version":"3.48.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,17]]},"DOI":"10.7759\/cureus.99491","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:13:11Z","timestamp":1766020391000},"source":"Crossref","is-referenced-by-count":0,"title":["Relapsing Blastic Plasmacytoid Dendritic Cell Neoplasm With Neurologic Involvement"],"prefix":"10.7759","author":[{"given":"Zehra","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Haley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Parza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JR","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13959","article-title":"Incidence, prognostic factors, and survival outcomes in patients with blastic plasmacytoid dendritic cell neoplasm: A retrospective study in the surveillance, epidemiology, and end results database","volume":"110","author":"Lin X","year":"2023","unstructured":"Lin X, Wang L, Hu Q, Zhu J, Tao Y, Huang L, Niu T. Incidence, prognostic factors, and survival outcomes in patients with blastic plasmacytoid dendritic cell neoplasm: A retrospective study in the surveillance, epidemiology, and end results database. Eur J Haematol. 2023, 110:743-53. 10.1111\/ejh.13959","journal-title":"Eur J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27737","article-title":"Blastic plasmacytoid dendritic cell neoplasm (BPDCN): 2025 update on diagnosis, pathophysiology, risk assessment, and management","volume":"100","author":"Shimony S","year":"2025","unstructured":"Shimony S, Luskin MR, Gangat N, LeBoeuf NR, Feraco AM, Lane AA. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): 2025 update on diagnosis, pathophysiology, risk assessment, and management. Am J Hematol. 2025, 100:1408-22. 10.1002\/ajh.27737","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cells13030243","article-title":"Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review of the disease, central nervous system presentations, and treatment strategies","volume":"13","author":"Mehra S","year":"2024","unstructured":"Mehra S, Taylor J. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review of the disease, central nervous system presentations, and treatment strategies. Cells. 2024, 13:243. 10.3390\/cells13030243","journal-title":"Cells"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000647","article-title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","volume":"3","author":"Garnache-Ottou F","year":"2019","unstructured":"Garnache-Ottou F, Vidal C, Biichl\u00e9 S, et al.. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?. Blood Adv. 2019, 3:4238-51. 10.1182\/bloodadvances.2019000647","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/107327481402100404","article-title":"Blastic plasmacytoid dendritic cell neoplasm: Update on molecular biology, diagnosis, and therapy","volume":"21","author":"Riaz W","year":"2014","unstructured":"Riaz W, Zhang L, Horna P, Sokol L. Blastic plasmacytoid dendritic cell neoplasm: Update on molecular biology, diagnosis, and therapy. Cancer Control. 2014, 21:279-89. 10.1177\/107327481402100404","journal-title":"Cancer Control"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34345","article-title":"Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics","volume":"128","author":"Adimora IJ","year":"2022","unstructured":"Adimora IJ, Wilson NR, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics. Cancer. 2022, 128:3019-26. 10.1002\/cncr.34345","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280843","article-title":"Treatment of leptomeningeal disease in blastic plasmacytoid dendritic cell neoplasm following tagraxofusp-erzs induction","volume":"107","author":"Vangala DB","year":"2022","unstructured":"Vangala DB, Nilius-Eliliwi V, Mika T, Gambichler T, Stranzenbach R, Schroers R. Treatment of leptomeningeal disease in blastic plasmacytoid dendritic cell neoplasm following tagraxofusp-erzs induction. Haematologica. 2022, 107:2004-7. 10.3324\/haematol.2022.280843","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2991\/chi.d.190218.001","article-title":"Therapeutic approaches for blastic plasmacytoid dendritic cell neoplasm: allogeneic hematopoietic cell transplantation and novel therapies","volume":"1","author":"Kharfan-Dabaja MA","year":"2019","unstructured":"Kharfan-Dabaja MA, Pemmaraju N, Mohty M. Therapeutic approaches for blastic plasmacytoid dendritic cell neoplasm: allogeneic hematopoietic cell transplantation and novel therapies. Clin Hematol Int. 2019, 1:2-9. 10.2991\/chi.d.190218.001","journal-title":"Clin Hematol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14146","article-title":"Blastic plasmacytoid dendritic cell neoplasm: Diagnostic criteria and therapeutical approaches","volume":"174","author":"Pagano L","year":"2016","unstructured":"Pagano L, Valentini CG, Grammatico S, Pulsoni A. Blastic plasmacytoid dendritic cell neoplasm: Diagnostic criteria and therapeutical approaches. Br J Haematol. 2016, 174:188-202. 10.1111\/bjh.14146","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2020.01.006","article-title":"Immunotherapies targeting CD123 for blastic plasmacytoid dendritic cell neoplasm","volume":"34","author":"Xue T","year":"2020","unstructured":"Xue T, Budde LE. Immunotherapies targeting CD123 for blastic plasmacytoid dendritic cell neoplasm. Hematol Oncol Clin North Am. 2020, 34:575-87. 10.1016\/j.hoc.2020.01.006","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/429476-relapsing-blastic-plasmacytoid-dendritic-cell-neoplasm-with-neurologic-involvement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:13:11Z","timestamp":1766020391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/429476-relapsing-blastic-plasmacytoid-dendritic-cell-neoplasm-with-neurologic-involvement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.99491","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}